Government proposes different levies for old and new products under statutory scheme
The Department of Health and Social Care has proposed changes to the statutory scheme for branded medicines pricing, including differing levy rates that are dependent on a product's age.
Manufacturers are required to pay the government a proportion of their net income from sales of branded medicines to the NHS under the statutory scheme
Shutterstock.com
The UK government has proposed restructuring its statutory scheme for branded medicine pricing by levying different rates on older and newer medicines.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
